1 Market Overview
1.1 Product Overview and Scope of Adoptive Cell Therapy
1.2 Classification of Adoptive Cell Therapy by Type
1.2.1 Overview: Global Adoptive Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Adoptive Cell Therapy Revenue Market Share by Type in 2020
1.2.3 CAR-T
1.2.4 TCR-T
1.2.5 NK
1.2.6 TIL
1.3 Global Adoptive Cell Therapy Market by Application
1.3.1 Overview: Global Adoptive Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Global Adoptive Cell Therapy Market Size & Forecast
1.5 Global Adoptive Cell Therapy Market Size and Forecast by Region
1.5.1 Global Adoptive Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Adoptive Cell Therapy Market Size by Region, (2016-2021)
1.5.3 North America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Adoptive Cell Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adoptive Cell Therapy Market Drivers
1.6.2 Adoptive Cell Therapy Market Restraints
1.6.3 Adoptive Cell Therapy Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Adoptive Cell Therapy Product and Solutions
2.1.4 Novartis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Juno
2.2.1 Juno Details
2.2.2 Juno Major Business
2.2.3 Juno Adoptive Cell Therapy Product and Solutions
2.2.4 Juno Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Juno Recent Developments and Future Plans
2.3 Kite
2.3.1 Kite Details
2.3.2 Kite Major Business
2.3.3 Kite Adoptive Cell Therapy Product and Solutions
2.3.4 Kite Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kite Recent Developments and Future Plans
2.4 Adaptimmune
2.4.1 Adaptimmune Details
2.4.2 Adaptimmune Major Business
2.4.3 Adaptimmune Adoptive Cell Therapy Product and Solutions
2.4.4 Adaptimmune Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Adaptimmune Recent Developments and Future Plans
2.5 Fibrocell
2.5.1 Fibrocell Details
2.5.2 Fibrocell Major Business
2.5.3 Fibrocell Adoptive Cell Therapy Product and Solutions
2.5.4 Fibrocell Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fibrocell Recent Developments and Future Plans
2.6 Lineage Cell Therapeutics
2.6.1 Lineage Cell Therapeutics Details
2.6.2 Lineage Cell Therapeutics Major Business
2.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Product and Solutions
2.6.4 Lineage Cell Therapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lineage Cell Therapeutics Recent Developments and Future Plans
2.7 BioTime
2.7.1 BioTime Details
2.7.2 BioTime Major Business
2.7.3 BioTime Adoptive Cell Therapy Product and Solutions
2.7.4 BioTime Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioTime Recent Developments and Future Plans
2.8 Vericel Corporation
2.8.1 Vericel Corporation Details
2.8.2 Vericel Corporation Major Business
2.8.3 Vericel Corporation Adoptive Cell Therapy Product and Solutions
2.8.4 Vericel Corporation Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vericel Corporation Recent Developments and Future Plans
2.9 Regeneus
2.9.1 Regeneus Details
2.9.2 Regeneus Major Business
2.9.3 Regeneus Adoptive Cell Therapy Product and Solutions
2.9.4 Regeneus Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Regeneus Recent Developments and Future Plans
2.10 Anhui Anke Biotechnology
2.10.1 Anhui Anke Biotechnology Details
2.10.2 Anhui Anke Biotechnology Major Business
2.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Product and Solutions
2.10.4 Anhui Anke Biotechnology Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Anhui Anke Biotechnology Recent Developments and Future Plans
2.11 Cellectis
2.11.1 Cellectis Details
2.11.2 Cellectis Major Business
2.11.3 Cellectis Adoptive Cell Therapy Product and Solutions
2.11.4 Cellectis Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cellectis Recent Developments and Future Plans
2.12 NantKwest
2.12.1 NantKwest Details
2.12.2 NantKwest Major Business
2.12.3 NantKwest Adoptive Cell Therapy Product and Solutions
2.12.4 NantKwest Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 NantKwest Recent Developments and Future Plans
2.13 SorrentoTherapeutics
2.13.1 SorrentoTherapeutics Details
2.13.2 SorrentoTherapeutics Major Business
2.13.3 SorrentoTherapeutics Adoptive Cell Therapy Product and Solutions
2.13.4 SorrentoTherapeutics Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 SorrentoTherapeutics Recent Developments and Future Plans
2.14 Bellicum
2.14.1 Bellicum Details
2.14.2 Bellicum Major Business
2.14.3 Bellicum Adoptive Cell Therapy Product and Solutions
2.14.4 Bellicum Adoptive Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Bellicum Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adoptive Cell Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Adoptive Cell Therapy Players Market Share
3.2.2 Top 10 Adoptive Cell Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Adoptive Cell Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Adoptive Cell Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Adoptive Cell Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021)
5.2 Adoptive Cell Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Adoptive Cell Therapy Revenue by Type (2016-2026)
6.2 North America Adoptive Cell Therapy Revenue by Application (2016-2026)
6.3 North America Adoptive Cell Therapy Market Size by Country
6.3.1 North America Adoptive Cell Therapy Revenue by Country (2016-2026)
6.3.2 United States Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Adoptive Cell Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Adoptive Cell Therapy Revenue by Type (2016-2026)
7.2 Europe Adoptive Cell Therapy Revenue by Application (2016-2026)
7.3 Europe Adoptive Cell Therapy Market Size by Country
7.3.1 Europe Adoptive Cell Therapy Revenue by Country (2016-2026)
7.3.2 Germany Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.3 France Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Adoptive Cell Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Adoptive Cell Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Adoptive Cell Therapy Revenue by Region (2016-2026)
8.3.2 China Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.5 India Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Adoptive Cell Therapy Revenue by Type (2016-2026)
9.2 South America Adoptive Cell Therapy Revenue by Application (2016-2026)
9.3 South America Adoptive Cell Therapy Market Size by Country
9.3.1 South America Adoptive Cell Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Adoptive Cell Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Adoptive Cell Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Adoptive Cell Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Adoptive Cell Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Adoptive Cell Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Adoptive Cell Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Novartis、Juno、Kite、Adaptimmune、Fibrocell、Lineage Cell Therapeutics、BioTime、Vericel Corporation、Regeneus、Anhui Anke Biotechnology、Cellectis、NantKwest、SorrentoTherapeutics、Bellicum
【免責事項】
https://www.globalresearch.jp/disclaimer